Press Releases

Press Releases

May 11, 2021
Establishment Labs Announces Participation in the UBS Global Healthcare Virtual Conference
SANTA BARBARA, Calif. --(BUSINESS WIRE)--May 11, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief
May 5, 2021
Establishment Labs Reports Record First Quarter 2021 Financial Results and Raises Full Year Guidance
SANTA BARBARA, Calif. --(BUSINESS WIRE)--May 5, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31,
April 27, 2021
Establishment Labs Completes Enrollment of One Hundred Patient Motiva Mia IRB Study
Establishment Labs Also Announces CE Mark Filing of Tools for Motiva Mia System SANTA BARBARA, Calif. --(BUSINESS WIRE)--Apr. 27, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction
April 14, 2021
Establishment Labs to Announce First Quarter 2021 Financial Results on May 5
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Apr. 14, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended March 31,
March 10, 2021
Establishment Labs Reports Fourth Quarter and Full Year 2020 Financial Results; Record Fourth Quarter Revenue of $27.0 Million
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Mar. 10, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year
February 24, 2021
Establishment Labs Announces Raj Denhoy Has Joined the Company as Head of Strategy and Investor Relations
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Feb. 24, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Raj Denhoy has been appointed Head of Strategy and
February 24, 2021
Establishment Labs to Announce Fourth Quarter 2020 Financial Results on March 10
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Feb. 24, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended December 31,
February 16, 2021
Establishment Labs Announces Participation in the Cowen 41st Annual Healthcare Conference
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Feb. 16, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief
February 9, 2021
Establishment Labs Hosts Investor Event for its Motiva MIA® System for Minimally Invasive Augmentation
Minimally Invasive creates a new product category in breast aesthetics with a total addressable market of $4-5 billion Clinical study shows significant benefits compared to traditional breast augmentation surgery, with procedures performed without general anesthesia and women experiencing faster
February 3, 2021
Establishment Labs Announces Participation in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Feb. 3, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief
Displaying 1 - 10 of 13